Stock UniverseDerived research view · source repositories remain read-only

NovoCure Limited (NVCR)

Life Science Tools / Diagnostics / MedTech · Healthcare / Medical Devices
Score Band
Watch
Selection Score
34.89
Global Rank
1285
Market Cap
1.56B
Latest Close
17.16
RS Composite
18.52% · G#489

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
4.03%
3M
31.60%
6M
45.30%
1Y
2.63%
3Y
-76.10%
5Y
-91.59%
10Y
54.18%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 2.14M · 30-day average: 1.85M · Max drawdown over stored range: -95.55%

Research Snapshot

Relative Strength vs SPX

RS Composite18.52%
20D RS1.33%
60D RS27.00%
120D RS18.63%
Global RS Rank489 · 85.42% percentile
Watch+Speculative RS Rank291 · 86.12% percentile
Group ScopeWatch+Speculative
Primary RS Rank14 · 90.14% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank86 / 246
Primary Percentile65.45
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-04-30674.41M507.13M-183.35M-173.05M-1.54-26.88M21.19M-48.07M112M75.20%-27.19%-25.66%-3.99%-7.13%87.53M195.46M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$-1.54-11.1x$6.002.9x$-0.43-40.1x$-0.24-71.8x

Shares Diluted: 112M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue494.366535.031537.84509.338605.22655.353
Revenue Growth (YoY)40.718%8.226%0.525%-5.299%18.825%8.283%
Gross Profit388.274420.793423.584381.803469.045490.184
Operating Income30.81-43.694-88.912-226.156-167.539-148.29
Free Cash Flow84.1858.5869.43-100.429-69.224-75.679
Free Cash Flow Per Share0.7730.5660.09-0.944-0.642-0.679
EPS (Diluted) GAAP0.18-0.564141-0.884135-1.949999-1.563759-1.222073
EPS Growth
EPS Non-GAAP
Gross Margin78.54%78.648%78.757%74.961%77.5%74.797%
Operating Margin6.232%-8.167%-16.531%-44.402%-27.682%-22.627%
Profit Margin4.007%-10.906%-17.205%-40.649%-27.862%-20.787%
Free Cash Flow Margin17.028%10.95%1.753%-19.718%-11.438%-11.548%
Shares Outstanding (Diluted)108.8776103.4333104.6605106.3912107.8344111.472
Shares Change (YoY)11.971%-5.0%1.186%1.654%1.356%3.373%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-04-30174.06M77.63%-67.42M-38.73%-71.14M-40.87%-0.62114.15M87.53M195.46Mprocessed
2025 Q42026-02-26174.35M75.82%-40.39M-23.17%-24.50M-14.05%-0.22112.11M93.55M195.05Mprocessed
2025 Q32025-10-30167.20M73.25%-36.02M-21.54%-37.27M-22.29%-0.33111.91M342.12M560.62Mprocessed
2025 Q22025-07-24158.81M73.88%-39.52M-24.89%-40.14M-25.28%-0.36111.57M149.62M559.79Mprocessed
2025 Q12025-04-24154.99M75.15%-37.87M-24.43%-34.32M-22.14%-0.31110.28M127.28M558.97Mprocessed
2024 Q42025-02-27161.27M79.25%-63.30M-39.25%-65.92M-40.88%-0.61108.30M163.77M97.30Mprocessed
2024 Q32024-10-30155.09M77.19%-32.09M-20.69%-30.57M-19.71%-0.28108.25M185.42M557.33Mprocessed
2024 Q22024-07-25150.36M76.95%-33.58M-22.33%-33.38M-22.20%-0.31107.70M164.80M556.51Mprocessed
2024 Q12024-05-02138.50M75.68%-41.52M-29.98%-38.76M-27.98%-0.36107.27M453.76M569.65Mprocessed
2023 Q42024-02-22133.78M75.67%-51.72M-38.66%-47.08M-35.19%-0.44106.91M240.82M568.82Mprocessed
2023 Q32023-10-26127.32M74.79%-58.24M-45.75%-49.48M-38.87%-0.46106.77M154.86M567.99Mprocessed
2023 Q22023-07-27126.05M73.01%-62.66M-49.71%-57.42M-45.55%-0.54106.29M156.98M567.15Mprocessed
2023 Q12023-05-04122.18M75.76%-60.25M-49.31%-53.06M-43.43%-0.50105.67M185.96M566.32Mprocessed
2022 Q42023-02-23128.43M77.51%-42.98M-33.46%-37.30M-29.05%-0.36104.98M115.33M565.51Mprocessed
2022 Q32022-10-27131.00M77.29%-24.61M-18.79%-26.58M-20.29%-0.25104.88M243.81M564.68Mprocessed
2022 Q22022-07-28140.87M79.77%-21.13M-15.00%-24.01M-17.04%-0.23104.63M367.01M563.85Mprocessed
2022 Q12022-04-28137.55M79.84%-806.00K-0.59%-4.65M-3.38%-0.04104.19M190.74M563.03Mprocessed
2021 Q42022-02-24133.21M77.71%-23.40M-17.56%-26.46M-19.86%-0.25103.89M208.80M562.22Mprocessed
2021 Q32021-10-28133.61M77.39%-8.55M-6.40%-13.12M-9.82%-0.13103.73M689.84M561.39Mprocessed
2021 Q22021-07-29133.52M78.58%-12.29M-9.21%-14.64M-10.97%-0.14103.48M349.12M560.56Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.